The AANS/NREF and ASTRO National Stereotactic Radiosurgery Quality Registry is a joint venture of organized neurosurgery and radiation oncology to define national patterns of care in radiosurgery. The goals are to identify gaps in treatment quality, measure comparative effectiveness and ultimately generate hypotheses for connections between care and outcomes. This work will also provide benchmark data and quality improvement tools for neurosurgeons to lead to enhanced quality during daily practice, maintenance of certification and accreditation. The study is open to patients undergoing stereotactic radiosurgery for an intracranial target (benign and malignant tumors, trigeminal neuralgia and vascular malformations). Patients with an expected survival of under two months or who are not expected to participate in a follow-up of at least two months are excluded from the study.
Currently, there are 23 sites participating in the SRS registry. So far, 3,785 patients have been included with 4,268 SRS plans submitted. Follow-up data is available for 2,728 patients to date. With more patient accrual and eventual data analysis, our long-term goals are to improve health care outcomes and potentially lower cost of care delivered to patients undergoing SRS treatment. We hope this work will facilitate the development of novel methods for conducting high-quality comparative effectiveness research in stereotactic radiosurgery and provide longitudinal data for outcome studies related to stereotactic radiosurgery. Ultimately, we hope to afford government agencies, corporate partners, medical insurance agencies and other third parties access to robust data pertaining to radiosurgical outcomes and quality.